In silico elucidation of potential drug targets against oxygenase domain of Human eNOS Dysfunction.

PLoS One · 2023 · PMC10132633 · PMID 37099543

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

The potential interacting residues (Val-104, Phe-105, Gln-247, Arg-250, Ala-266, Trp-330, Tyr-331, Pro-334, Ala-335, Val-336, Tyr-357, Met-358, Thr-360, Glu-361, Ile-362, Arg-365, Asn-366, Asp-369, Arg-372, Trp-447, Tyr-475) identified by molecular docking analyses may be significant for site-directed mutagenesis.

also in 3,829 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.